Exposure to Bisphenol A and Other Phenols in Neonatal Intensive Care Unit Premature Infants

Objective We previously demonstrated that exposure to polyvinyl chloride plastic medical devices containing di(2-ethylhexyl) phthalate (DEHP) was associated with higher urinary concentrations of several DEHP metabolites in 54 premature infants in two neonatal intensive care units than in the general population. For 42 of these infants, we evaluated urinary concentrations of several phenols, including bisphenol A (BPA), in association with the use of the same medical devices. Measurements We measured the urinary concentrations of free and total (free plus conjugated) species of BPA, triclosan, benzophenone-3, methyl paraben, and propyl paraben. Results The percentage of BPA present as its conjugated species was > 90% in more than three-quarters of the premature infants. Intensity of use of products containing DEHP was strongly associated with BPA total concentrations but not with any other phenol. Adjusting for institution and sex, BPA total concentrations among infants in the group of high use of DEHP-containing products were 8.75 times as high as among infants in the low use group (p < 0.0001). Similarly, after adjusting for sex and DEHP-containing product use category, BPA total concentrations among infants in Institution A were 16.6 times as high as those among infants in Institution B (p < 0.0001). Conclusion BPA geometric mean urinary concentration (30.3 μg/L) among premature infants undergoing intensive therapeutic medical interventions was one order of magnitude higher than that among the general population. Conjugated species were the primary urinary metabolites of BPA, suggesting that premature infants have some capacity to metabolize BPA. The differences in exposure to BPA by intensity of use of DEHP-containing medical products highlight the need for further studies to determine the specific source(s) of exposure to BPA.

[1]  Aschberger Karin,et al.  European Union Risk Assessment Report - Environment Addendum of April 2008 - 4,4'-ISOPROPYLIDENEDIPHENOL (BISPHENOL-A) - Part 1 Environment , 2010 .

[2]  Kristina A. Thayer,et al.  Environmental toxins: Exposure to bisphenol A advances puberty , 1999, Nature.

[3]  A. Calafat,et al.  Quantification of the urinary concentrations of parabens in humans by on-line solid phase extraction-high performance liquid chromatography-isotope dilution tandem mass spectrometry. , 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[4]  G. Mulder,et al.  New developments in glucuronidation research: Report of a workshop on “Glucuronidation, its role in health and disease” , 1992, Hepatology.

[5]  Julie E Goodman,et al.  An Updated Weight of the Evidence Evaluation of Reproductive and Developmental Effects of Low Doses of Bisphenol A , 2006, Critical reviews in toxicology.

[6]  C. Sonnenschein,et al.  Induction of mammary gland ductal hyperplasias and carcinoma in situ following fetal bisphenol A exposure. , 2007, Reproductive toxicology.

[7]  W. Rutala,et al.  Use of Germicides in the Home and the Healthcare Setting Is There a Relationship Between Germicide Use and Antibiotic Resistance? , 2006, Infection Control &#x0026; Hospital Epidemiology.

[8]  Y. Kuroda,et al.  Behavioral Alterations in Response to Fear-Provoking Stimuli and Tranylcypromine Induced by Perinatal Exposure to Bisphenol A and Nonylphenol in Male Rats , 2004, Environmental health perspectives.

[9]  A. Aloisi,et al.  Pubertal exposure to estrogenic chemicals affects behavior in juvenile and adult male rats , 2006, Hormones and Behavior.

[10]  A. Calafat,et al.  Temporal stability of the conjugated species of bisphenol A, parabens, and other environmental phenols in human urine , 2007, Journal of Exposure Science and Environmental Epidemiology.

[11]  A. Piersma,et al.  State of the art in developmental toxicity screening methods and a way forward: a meeting report addressing embryonic stem cells, whole embryo culture, and zebrafish. , 2008, Birth defects research. Part B, Developmental and reproductive toxicology.

[12]  Yoshiki Katayama,et al.  Human exposure to bisphenol A. , 2006, Toxicology.

[13]  M. Schlumpf,et al.  In vitro and in vivo estrogenicity of UV screens. , 2001, Environmental health perspectives.

[14]  Antonia M. Calafat,et al.  Use of Di(2-ethylhexyl) Phthalate–Containing Medical Products and Urinary Levels of Mono(2-ethylhexyl) Phthalate in Neonatal Intensive Care Unit Infants , 2005, Environmental health perspectives.

[15]  J. Newman,et al.  Triclosan: a review of effectiveness and safety in health care settings. , 2000, American journal of infection control.

[16]  M. Shelby.  NTP-CERHR monograph on the potential human reproductive and developmental effects of bisphenol A. , 2008, NTP CERHR MON.

[17]  P. Darbre,et al.  Paraben esters: review of recent studies of endocrine toxicity, absorption, esterase and human exposure, and discussion of potential human health risks , 2008, Journal of applied toxicology : JAT.

[18]  R. Hornung,et al.  Estimation of Average Concentration in the Presence of Nondetectable Values , 1990 .

[19]  S. Parmigiani,et al.  Developmental exposure to low-dose estrogenic endocrine disruptors alters sex differences in exploration and emotional responses in mice , 2007, Hormones and Behavior.

[20]  Joshua T. Cohen,et al.  Weight of the Evidence Evaluation of Low-Dose Reproductive and Developmental Effects of Bisphenol A , 2004 .

[21]  Carlos Sonnenschein,et al.  Prenatal Bisphenol A Exposure Induces Preneoplastic Lesions in the Mammary Gland in Wistar Rats , 2006, Environmental health perspectives.

[22]  C. Hughes,et al.  An Extensive New Literature Concerning Low-Dose Effects of Bisphenol A Shows the Need for a New Risk Assessment , 2005, Environmental health perspectives.

[23]  B. Burchell,et al.  Development of multiple activities of UDP-glucuronyltransferase in human liver. , 1987, The Biochemical journal.

[24]  Laura N. Vandenberg,et al.  Human exposure to bisphenol A (BPA). , 2007, Reproductive toxicology.

[25]  G. Kearns,et al.  Ontogeny of drug metabolizing enzymes in the neonate. , 2005, Seminars in fetal & neonatal medicine.

[26]  J. Weuve,et al.  Exposure to Phthalates in Neonatal Intensive Care Unit Infants: Urinary Concentrations of Monoesters and Oxidative Metabolites , 2006, Environmental health perspectives.

[27]  A. Wennberg,et al.  Percutaneous absorption of the sunscreen benzophenone‐3 after repeated whole‐body applications, with and without ultraviolet irradiation , 2006, The British journal of dermatology.

[28]  M. Jackson,et al.  Development of human liver UDP-glucuronosyltransferases. , 1989, Developmental pharmacology and therapeutics.

[29]  Susan R Woskie,et al.  NTP-CERHR expert panel report on the reproductive and developmental toxicity of bisphenol A. , 2008, Birth defects research. Part B, Developmental and reproductive toxicology.

[30]  P. Palanza,et al.  d-Amphetamine-related reinforcing effects are reduced in mice exposed prenatally to estrogenic endocrine disruptors , 2005, Brain Research Bulletin.

[31]  A. Olshan,et al.  NTP-CERHR Expert Panel Report on the reproductive and developmental toxicity of 2-bromopropane. , 2004, Reproductive toxicology.

[32]  Frederick S vom Saal,et al.  Estrogenic chemicals in plastic and oral contraceptives disrupt development of the fetal mouse prostate and urethra. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[33]  A. Calafat,et al.  Concentrations of the Sunscreen Agent Benzophenone-3 in Residents of the United States: National Health and Nutrition Examination Survey 2003–2004 , 2008, Environmental health perspectives.

[34]  E. Warshaw,et al.  Parabens: a review of epidemiology, structure, allergenicity, and hormonal properties. , 2005, Dermatitis : contact, atopic, occupational, drug.

[35]  Shuk-Mei Ho,et al.  4 Epigenetically Regulates Phosphodiesterase Type 4 Variant Increases Susceptibility to Prostate Carcinogenesis and Developmental Exposure to Estradiol and Bisphenol A , 2006 .

[36]  John Keenan Taylor.  Quality Assurance of Chemical Measurements , 1981 .

[37]  S. Parmigiani,et al.  Exposure to a low dose of bisphenol A during fetal life or in adulthood alters maternal behavior in mice. , 2002, Environmental health perspectives.

[38]  A. Calafat,et al.  Urinary Concentrations of Triclosan in the U.S. Population: 2003–2004 , 2007, Environmental health perspectives.

[39]  A. Calafat,et al.  Parabens as Urinary Biomarkers of Exposure in Humans , 2006, Environmental health perspectives.

[40]  undefined Fda,et al.  Safety assessment of Di-(2-ethylhexyl) phthalate (DEHP) released from PVC medical devices , 2001 .

[41]  A. Calafat,et al.  Automated on-line column-switching HPLC-MS/MS method with peak focusing for the determination of nine environmental phenols in urine. , 2005, Analytical chemistry.

[42]  A. Calafat,et al.  Exposure to di-(2-ethylhexyl) phthalate among premature neonates in a neonatal intensive care unit. , 2004, Pediatrics.

[43]  Julie E. Goodman,et al.  Weight-of-Evidence Evaluation of Reproductive and Developmental Effects of Low Doses of Bisphenol A , 2009 .

[44]  Antonia M. Calafat,et al.  Exposure of the U.S. Population to Bisphenol A and 4-tertiary-Octylphenol: 2003–2004 , 2007, Environmental health perspectives.

[45]  E. Mcconnell,et al.  Weight-of-evidence evaluation of reproductive and developmental effects of low doses of bisphenol A. , 2009, Critical reviews in toxicology.

[46]  J. Vandenbergh,et al.  Developmental exposure to environmental estrogens alters anxiety and spatial memory in female mice , 2006, Hormones and Behavior.

[47]  A. Aloisi,et al.  Estrogenic chemicals at puberty change ERalpha in the hypothalamus of male and female rats. , 2007, Neurotoxicology and teratology.